SAICAR is an intermediate in de novo purine nucleotide biosynthesis and acts as an allosteric activator of PKM2 with an EC50 of 0.3 mM; it promotes cancer cell survival under glucose-limiting conditions by stimulating PKM2 activity, inducing nuclear localization of PKM2, and facilitating sustained Erk1/2 activation and mitogen-induced cell proliferation; the SAICAR-PKM2 interaction is necessary and sufficient to induce H3T11 and Erk1/2 phosphorylation.